Zobrazeno 1 - 10
of 145
pro vyhledávání: '"Juan G Puig"'
Autor:
Juan G. Puig, Rosa J. Torres
Publikováno v:
Nucleosides, Nucleotides and Nucleic Acids. 37:261-272
The neurological manifestations of Lesch-Nyhan disease (LND) have been attributed to the effect of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency on nervous system development. An increase has been reported in the levels of 5-aminoi
Autor:
Juan G. Puig, Rosa J. Torres
Publikováno v:
Journal of Human Genetics. 62:1079-1083
X chromosome inactivation (XCI) ratios of normal females can range from a highly skewed ratio of 0:100 to a 50:50 ratio. In several X-linked disorders, female carriers present skewed X inactivation. Hypoxanthine–guanine phosphoribosyltransferase (H
Publikováno v:
Nucleosides, Nucleotides & Nucleic Acids. 35:507-516
Lesch-Nyhan disease is caused by HGprt deficiency, however, the mechanism by which enzyme deficiency leads to the severe neurological manifestations is still unknown. We hypothesized that hypoxanthine excess leads, directly or indirectly, through its
Autor:
Hyder A. Jinnah, Juan G. Puig, Rosa J. Torres, Christopher C. Porter, Gul Yalcin-Cakmakli, Araceli Menendez, Hasan Fatih Çakmaklı
Publikováno v:
Genetics in medicine : official journal of the American College of Medical Genetics
Purpose Lesch-Nyhan disease (LND) is an inherited metabolic disorder characterized by overproduction of uric acid and neurobehavioral abnormalities. The purpose of this study is to describe macrocytic erythrocytes as another common aspect of the phen
Autor:
Rosa J. Torres, Juan G. Puig
Publikováno v:
Journal of Inherited Metabolic Disease. 38:1109-1118
Neurological manifestations in Lesch-Nyhan disease (LND) are attributed to the effect of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency on the nervous system development. HPRT deficiency causes the excretion of increased amounts of
Autor:
Celso Amodeo, Marco Antonio Alcocer Gamba, Irina Chazova, Jean-Jacques Mourad, Juan G. Puig, Stefano Taddei, Roland Asmar, Giuseppe Mancia
Publikováno v:
Journal of Hypertension. 33:401-411
Objectives: An international double-blind, parallel-group, randomized controlled trial was performed to determine the efficacy and safety of a new first-line strategy in mild to moderate hypertension based on a single-pill combination of perindopril/
Autor:
Matthijs Janssen, Alexander So, Marilyn E. Merriman, Edward Roddy, Lisa K. Stamp, Philip Riches, Ruth Topless, Robert J. Walker, Twj Huizinga, Tony R. Merriman, Lab Joosten, Mariano Andrés, Murray Cadzow, J. de Zoysa, Matthew A. Brown, Geraldine M. McCarthy, Karel Pavelka, Christopher Hill, Fernando Perez-Ruiz, E. de Guzman, Donia Macartney-Coxson, Blanka Stiburkova, Nicola Dalbeth, Ken Yamamoto, Rosa J. Torres, Amanda Phipps-Green, T.L. Jansen, T R D J Radstake, Katie Cremin, Fina A S Kurreeman, S. Lester, Rinki Murphy, R. Stubbs, Linda A. Bradbury, Michael Doherty, E Stahl, Russell R C Buchanan, Abhishek Abhishek, A.-K. Tausche, Hirotaka Matsuo, Sally P.A. McCormick, Hyon K. Choi, Tanya J Flynn, Frédéric Lioté, Maureen Rischmueller, Juan G. Puig, Malcolm D. Smith
Publikováno v:
Poster Presentations.
Background Gout progresses through three stages: hyperuricemia, deposition of monosodium urate (MSU) crystals, and innate immune system response to MSU crystals. Genome wide association studies (GWAS) have provided insight into the molecular control
Publikováno v:
The Journal of Rheumatology. 41:1863-1870
Objective.Primary gout has been associated with single-nucleotide polymorphisms (SNP) in several tubular urate transporter genes. No study has assessed the association of reabsorption and secretion urate transporter gene SNP with gout in a single coh
Autor:
M Teresa Rodríguez, Juan G. Puig, M Luisa Llena, Nicolás M González Senac, Rosa J. Torres, Marta Migoya, Rebeca Bailén, Mónica M López, Eugenio de Miguel
Publikováno v:
Nucleosides, Nucleotides and Nucleic Acids. 33:174-180
Pharmacologic urate lowering therapy (ULT), at full maintenance doses, has been associated with acute gout arthritis (in up to 80% of patients). The American College of Rheumatology has recently advocated gradually titrating the maintenance dose upwa
Publikováno v:
Nucleosides, Nucleotides and Nucleic Acids. 33:185-191
Primary gout has traditionally been associated with obesity, arterial hypertension, and abnormal lipid and glucose homeostasis, but we do not know the prevalence of these vascular risk factors in patients with primary gout from a Mediterranean countr